People · Operator
Named in public records as an officer, director or promoter · active 2017–2026 · Pharma, Biotechnology, Retailing
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Elevation Oncology, Inc. | — | Pharma | Series C | $70.5M | $2.0B | 2020 |
| AirNexis Therapeutics, Inc. | — | Biotechnology | Series C | $62.0M | $309.3M | 2026 |
| Deva Parent Holdings, Inc. | — | Retailing | Pre-Seed | $200K | $1.6M | 2017 |
Colin Walsh at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Colin Walsh on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Gaster | 1 | 7 |
| Steven Elms | 1 | 5 |
| Joseph Robinson | 1 | 5 |
| Dennis Gies | 1 | 4 |
| Jill Carroll | 1 | 4 |
| Lori Hu | 1 | 3 |
| Maria Fardis | 1 | 3 |
| Anna Chen | 1 | 3 |
| Andrew Phillips | 1 | 3 |
| Michael Caldwell | 1 | 2 |
| Evan Caplan | 1 | 2 |
| Rachel Lee | 1 | 2 |
| Timothy Clackson | 1 | 2 |
| Megan Streeter | 1 | 1 |
| Shawn Leland | 1 | 1 |
| James Li | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.